---
title: "Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board | PLRX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286582018.md"
description: "Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board | PLRX Stock News"
datetime: "2026-05-15T06:25:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286582018.md)
  - [en](https://longbridge.com/en/news/286582018.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286582018.md)
generator: "portal-rs"
---

# Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board | PLRX Stock News

Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board | PLRX Stock News

### Related Stocks

- [PLRX.US](https://longbridge.com/en/quote/PLRX.US.md)

## Related News & Research

- [Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News](https://longbridge.com/en/news/287275540.md)
- [Canaccord Genuity Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)](https://longbridge.com/en/news/295789301.md)
- [Here's How Much $100 Invested In Mastercard 20 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296552952.md)
- [Mastercard Incorporated $MA Shares Bought by TD Waterhouse Canada Inc.](https://longbridge.com/en/news/296462180.md)
- [Vise Technologies Inc. Takes $743,000 Position in Halozyme Therapeutics, Inc. $HALO](https://longbridge.com/en/news/296763264.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**